Publications
- Long-term impact of adalimumab therapy on biomarkers of systemic inflammation in psoriasis: Results of a 2 year study2020 | Third Faculty of Medicine
- Management of Moderate to Severe Plaque Psoriasis with Brodalumab in Daily Practice: Real-World Evidence from the LIBERO Study in the Czech Republic2024 | Third Faculty of Medicine, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Case studies in dermatology2021 | Third Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport, Faculty of Medicine in Pilsen
- Acrodermatitis continua Hallopeau successfully treated by risankizumab2021 | Third Faculty of Medicine
- The Influence of Long Term Therapy with Adalimumab on Biomarkers of Systemic Inflammation in Psoriasis2021 | Third Faculty of Medicine
- 6 Ixekizumab v léčbě genitální psoriázy2021 | Third Faculty of Medicine
- Psoriáza v dětském věku2021 | Third Faculty of Medicine
- Psoriasis treatment with adalimumab in clinical practice: long-term experience in a center for biological therapy in the Czech Republic2018 | Third Faculty of Medicine
- Impact of adalimumab treatment on cardiovascular risk biomarkers in psoriasis: Results of a pilot study2017 | Third Faculty of Medicine
- A case of acute generalized pustular psoriasis of von Zumbusch treated with adalimumab2015 | Third Faculty of Medicine
Loading network view...